Skip to main content
SpringerLink
Log in

Recent Progress in Gonadotropin Therapy

  • Chapter
Ovulation Induction

Part of the book series: Clinical Perspectives in Obstetrics and Gynecology ((CPOG))

  • 113 Accesses

Abstract

Since the induction of ovulation with human pituitary gonadotropins (hPG) was first achieved in 1958,1 exogenous gonadotropin therapy has been successful in anovulatory infertile women. Ovulation induction using exogenous gonadotropins can be achieved in amenorrheic women with functional ovarian tissue.2–5 Women with chronic anovulation who fail to ovulate with clomiphene citrate, either alone or with human chorionic gonadotropin (hCG), can also be candidates for treatment.6–8

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gemzell CA, Diczfalusy E, Tillinger KG. Clinical effect of human pituitary follicle stimulating hormone (FSH). J Clin Endocrinol Metab. 1958; 18: 1333–48.

    PubMed  CAS  Google Scholar 

  2. Jones KP, Ravnikar VA, Schiff I. Results of human menopausal gonadotropin therapy at the Boston Hospital for Women (1979–1981). Int J Fertil. 1987; 32: 131–34.

    PubMed  CAS  Google Scholar 

  3. Kennedy JL, Adashi EY. Ovulation induction. Obstet Gynecol Clin North Am. 1987; 14: 831–64.

    PubMed  CAS  Google Scholar 

  4. March CM, Davajan V, Mishell DR Jr. Ovulation induction in amenorrheic women. Obstet Gynecol. 1979; 53: 8–11.

    PubMed  CAS  Google Scholar 

  5. March CM. Therapeutic regimens and monitoring techniques for human menopausal gonadotropin administration. J Reprod Med. 1978; 21: 198–204.

    PubMed  CAS  Google Scholar 

  6. Raj SG, Berger MJ, Grimes EM, et al. The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril. 1977; 28: 1280–84.

    PubMed  CAS  Google Scholar 

  7. Seibel MM, McArdle C, Smith D, Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril. 1985; 43: 703–08.

    PubMed  CAS  Google Scholar 

  8. Venturoli S, Paradisi R, Fabbri R, et al. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstet Gynecol. 1984; 63: 6–11.

    PubMed  CAS  Google Scholar 

  9. Kurachi K, Aono T, Suzuki M. Results of hMG-hCG therapy in 1096 treatment cycles of 2166 Japanese women with anovulatory infertility. Eur J Obstet Gynecol Reprod Biol. 1985; 19: 43–52.

    CAS  Google Scholar 

  10. Kremmann E, Tavakoli F, Shelden RM, et al. Induction of ovulation with menotropins in women with polycystic ovary syndrome. Am J Obstet Gynecol. 1981; 141: 58–64.

    Google Scholar 

  11. Check JH. Treatment of cervical factor with combined high-dose estrogen and human menopausal gonadotropins. Fertil Steril. 1980; 33: 562–63.

    PubMed  CAS  Google Scholar 

  12. Check JH, Adelson HG. Improvement of cervical factor by high-dose estrogen and human menopausal gonadotropin therapy with ultrasound monitoring. Obstet Gynecol. 1984; 63: 179–81.

    PubMed  CAS  Google Scholar 

  13. Check JH, Wu CH, Dietterich C, et al. The treatment of cervical factor with ethinyl estradiol and human menopausal gonadotropins. Int J Fertil. 1986; 31: 148–52.

    PubMed  CAS  Google Scholar 

  14. Lunenfeld B, Insler V. Gonadotropins. In: Diagnosis and treatment of functional infertility. Berlin: Grosse Verlag, 1978: 76–89.

    Google Scholar 

  15. Welner S, DeCherney AH, Polan ML. Human menopausal gonadotropins: a justifiable therapy in ovulatory women with long-standing idiopathic infertility. Am J Obstet Gynecol. 1988; 158: 111–17.

    PubMed  CAS  Google Scholar 

  16. Halme J, Hammond MG, Bailey L, et al. Lower doses of human menopausal gonadotropin are associated with improved success with in vitro fertilization in women with low body weight. Am J Obstet Gynecol. 1988; 158: 64–65.

    PubMed  CAS  Google Scholar 

  17. Ben-Rafael Z, Benadiva CA, Ausmanas M, et al. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril. 1987; 48: 964–68.

    PubMed  CAS  Google Scholar 

  18. Bernardus RE, Jones GS, Acosta M, et al. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth. Fertil Steril. 1985; 43: 373–78.

    PubMed  CAS  Google Scholar 

  19. Cohen JJ, Debache C, Pigeau F, et al. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles. Fertil Steril. 1984; 42: 360–65.

    PubMed  CAS  Google Scholar 

  20. Zondek B, Aschheim S. Des Hormon des hypophysenvorderlappens. Klin Wochenschr. 1928; 6: 831–35.

    Google Scholar 

  21. Schwartz J, Jewelewicz R. The use of gonadotropins for induction of ovulation. Fertil Steril. 1981; 35: 3–12.

    PubMed  CAS  Google Scholar 

  22. Smith PE, Engle ET. Experimental evidence regarding the role of anterior pituitary in the development and regulation of the genital system. Am J Anat. 1927; 40: 159–217.

    Google Scholar 

  23. Cole HH, Hart GH. The potency of blood serum of mares in progressive stages of pregnancy in effecting the sexual maturity of immature rats. Am J Physiol 1930; 93: 57–68.

    CAS  Google Scholar 

  24. Hamblen EC, Davis CD. Treatment of hypoovarianism by the sequential and cyclic administration of equine and chorionic gonadotropins. Am J Obstet Gynecol. 1945; 50: 137–46.

    Google Scholar 

  25. Borth R, Lunenfeld B, de Watteville H. Activite gonadotrope d’un extrait d’urines de femmes en menopause. Experientia. 1954; 10: 264–68.

    Google Scholar 

  26. Borth R, Lunenfeld B, Riotton G, et al. Activite gonadotrope d’un extrait des femmes en menopause (2e communication). Experientia. 1957; 13: 115–17.

    PubMed  CAS  Google Scholar 

  27. Lunenfeld B, Menzi A, Volet B. Clinical effects of a human postmenopausal gonadotropin. Rass Clin Ter Sci Affini. 1960; 59: 213–16.

    CAS  Google Scholar 

  28. Donini P, Puzuli D, Montezeniola R. Purification of gonadotropins from human menopause urine. Acta Endocrinol. 1964; 45: 329–34.

    PubMed  CAS  Google Scholar 

  29. Borth R, Lunenfeld B, Menzi A. Pharmacologie and clinical effects of a gonadotropin preparation from human postmenopausal urine. In: Albert A, Thomas MC, eds. Human pituitary gonadotropins. Springfield: Charles C. Thomas, 1961: 255.

    Google Scholar 

  30. Blankstein J, Mashiach, Lunenfeld B. Induction of ovulation with gonadotropins. In: Ovulation induction and in vitro fertilization. Chicago: Year Book, 1986: 131–54.

    Google Scholar 

  31. Rosemberg E, Cortes-Prieto J. First demonstration of induction of ovulation with a hybrid human chorionic gonadotropin compound (AB1ER-CR-2XY). Fertil Steril. 1983; 40: 790–97.

    PubMed  CAS  Google Scholar 

  32. Richards JA, Hedin L. Molecular aspects of hormone action in ovarian follicular development, ovulation and luteinization. Annu Rev Physiol. 1988; 50: 441–64.

    PubMed  CAS  Google Scholar 

  33. Dlugi AM, Laufer N, DeCherney AH, et al. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro fertilization cycles. J In Vitro Fertil Embryo Transfer. 1985; 2: 33–40.

    CAS  Google Scholar 

  34. Vermesh M, Kletzky OA. Follicle-stimulating hormone is the main determinant of follicular recruitment and development in ovulation induction with human menopausal gonadotropin. Am J Obstet Gynecol. 1987; 157: 1397–1402.

    PubMed  CAS  Google Scholar 

  35. Diamond MP, Wentz AC. Ovulation induction with human menopausal gonadotropins. Obstet Gynecol Surv. 1986; 41: 480–90.

    PubMed  CAS  Google Scholar 

  36. Filicori M, Santoro N, Merriam GR, et al. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 1986; 62: 1136–44.

    PubMed  CAS  Google Scholar 

  37. Collins RL, Sopelak V, Williams RF, et al. Prevention of GnRH antagonist-induced lu-teal regression by concurrent exogenous pulsatile gonadotrophin administration in monkeys. Fertil Steril. 1986; 46: 945–53.

    PubMed  CAS  Google Scholar 

  38. Groff T, Raj HGM, Talbert LM, et al. Effects of neutralization of luteinizing hormone on corpus luteum function and cyclicity in Ma-caca fascicularis. J Clin Endocrinol Metab. 1984; 59: 1054–57.

    PubMed  CAS  Google Scholar 

  39. Coelingh Bennink HJT. Pulsatile administration of LHRH for ovulation induction. In: Shaw RW, Marshall JC, eds. LHRH and its analogues. Their use in gynaecological practice. London: Wright Press, 1989: 92–112.

    Google Scholar 

  40. Mais V, Kazer RR, Cetel NS, et al. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. J Clin Endocrinol Metab. 1986; 62: 1250–55.

    PubMed  CAS  Google Scholar 

  41. Weinstein FG, Seibel MM, Taymor ML. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone: the role of supplemental human chorionic gonadotropin in the luteal phase. Fertil Steril. 1984; 41: 546–50.

    PubMed  CAS  Google Scholar 

  42. Zeleznik AJ, Hutchison JS. The use of pulsatile GnRH treatment to investigate the regulation of the primate corpus luteum. In: Coelingh Bennink HJT, Dogterom AA, Lappohn RE, et al., eds. Pulsatile GnRH 1985. Naarlem, The Netherlands: Ferring, 1986: 71–79.

    Google Scholar 

  43. Berger NG, Zacur HA. Exogenous progesterone for luteal support following gonodatropin-releasing hormone ovulation induction: case report. Fertil Steril. 1985; 44: 133–35.

    PubMed  CAS  Google Scholar 

  44. Kenigsberg D, Littman BA, Williams RF, et al. Medical hypophysectomy. II: variability of ovarian response to exogenous gonadotropins. Fertil Steril. 1984; 42: 116–26.

    PubMed  CAS  Google Scholar 

  45. Cook AS, Webster BW, Terranova PF, et al. Variation in the biologic and biochemical characteristics of human menopausal gonadotropin. Fertil Steril. 1988; 49: 704–12.

    PubMed  CAS  Google Scholar 

  46. Seibel M. Toward understanding the pathophysiology and treatment of polycystic ovarian disease. Semin Reprod Endocrinol. 1984; 2: 297–304.

    Google Scholar 

  47. Traub Al, McFaul PB, Sheridan B, et al. Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels. Clin Reprod Fertil. 1987; 5: 167–71.

    PubMed  CAS  Google Scholar 

  48. Hoffman DI, Lobo RA, Campeau J, et al. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone. J Clin Endocrinol Metab. 1985; 60: 922–27.

    PubMed  CAS  Google Scholar 

  49. Couzinet B, Lestrat N, Brailly S, et al. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab. 1988; 66: 552–56.

    PubMed  CAS  Google Scholar 

  50. Reid RL, Fretts R, Van Vugt DA. The theory and practice of ovulation induction with gonadotropin-releasing hormone. Am J Obstet Gynecol. 1988; 158: 173–85.

    Google Scholar 

  51. Sueldo CE, Swanson JA. The economics of inducing ovulation with human menopausal gonadotropins versus pulsatile subcutaneous gonadotropin-releasing hormone. Fertil Steril. 1986; 45: 128–29.

    PubMed  CAS  Google Scholar 

  52. Dawood MY, Jarrett JC 2d, Choe JK. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Fertil Steril. 1982; 38: 415–18.

    PubMed  CAS  Google Scholar 

  53. Farine D, Mashiach S, Ben-Rafael Z, et al. Retrospective evaluation of human menopausal gonadotropin and human chorionic gonadotropin induction of ovulation in galactorrheic and hyperprolactinemic women. Fertil Steril. 1982; 38: 187–89.

    PubMed  CAS  Google Scholar 

  54. Tang GW, Tang LC, Ho PC. Transient hyperprolactinaemia in human menopausal gonadotropin induction of ovulation. Int J Fertil. 1984; 29: 136–40.

    PubMed  CAS  Google Scholar 

  55. Check JH, Chase JS. Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy. Fertil Steril. 1984; 42: 919–22.

    PubMed  CAS  Google Scholar 

  56. Fleming R, Hamilton MP, Barlow DH, et al. Pregnancy after ovulation induction in a patient with menopausal gonadotropin levels after chemotherapy [letter]. Lancet. 1984; 1399.

    Google Scholar 

  57. Jones GS, Aziz A, Urbina G. Clinical use of gonadotropins in conditions of ovarian insufficiency of various etiologies. Fertil Steril. 1961; 12: 217–35.

    PubMed  CAS  Google Scholar 

  58. Zimmerman R, Soor B, Braendle W, et al. Gonadotropin therapy of female infertility: analysis of results in 416 cases. Gynecol Obstet Invest. 1982; 14: 1–6.

    Google Scholar 

  59. Dodson WC, Whitesides DB, Hughes CL, et al. Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization. Fertil Steril. 1987; 48: 441–45.

    PubMed  CAS  Google Scholar 

  60. Taymor ML, Yussman MA, Gmisnki D. Estrogen monitoring in ovulation induction. Fertil Steril. 1970; 21: 759–62.

    PubMed  CAS  Google Scholar 

  61. Webb-Wilson GJ, Arronet GH. Ovulation induction with human menopausal gonadotropins: an evaluation of a variable daily dosage regimen. Int J Fertil. 1977; 22: 225–29.

    PubMed  CAS  Google Scholar 

  62. Klopper A, Aiman J, Besser M. Ovarian steroidogenesis resulting from treatment with menopausal gonadotropin. Eur J Obstet Gynecol Reprod Biol. 1974; 4: 25–28.

    PubMed  CAS  Google Scholar 

  63. Shaaban MM, Klopper A. Plasma oestradiol and progesterone concentration in the normal menstrual cycle. J Obstet Gynaecol Br Commonw. 1973; 80: 776–80.

    PubMed  CAS  Google Scholar 

  64. Tredway DR, Goebelsmann U, Thorneycroft IH, et al. Monitoring induction of ovulation with human menopausal gonadotropin by a rapid estrogen radioimmunoassay. Am J Ob-stet Gynecol 1974; 120: 1035–39.

    CAS  Google Scholar 

  65. Schenker JG, Weinstein D. Ovarian hyper-stimulation syndrome: a current survey. Fertil Steril. 1978; 30: 255–68.

    PubMed  CAS  Google Scholar 

  66. Haning RV, Levin RM, Behrman HR, et al. Plasma estradiol window and urinary estriol glucuronide determinations for monitoring menotropin induction of ovulation. Obstet Gynecol. 1979; 54: 442–47.

    PubMed  CAS  Google Scholar 

  67. Duff GB. Ultrasound and ovulation. NZ Med J. 1987; 100: 657–59.

    CAS  Google Scholar 

  68. Robinson RD, Packer RH, Wilson PC, et al. Assessment of ovulation by ultrasound and plasma estradiol determination. Obstet Gynecol. 1979; 54: 686–91.

    Google Scholar 

  69. O’Herlihy C, deCrespigny LJC, Robinson HP. Monitoring ovarian follicular development with real-time ultrasound. Br J Obstet Gynaecol 1980; 87: 613–17.

    PubMed  Google Scholar 

  70. Cabau A, Bessis R. Monitoring of ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin by ultrasound. Fertil Steril. 1981; 36: 178–82.

    PubMed  CAS  Google Scholar 

  71. Dornbluth NC, Potter JL, Shepard MK, et al. Assessment of follicular development by ultrasonography and total serum estrogen in human menopausal gonadotropin-stimulated cycles. J Ultrasound Med. 1983; 2: 407–12.

    PubMed  CAS  Google Scholar 

  72. Hull ME, Moghissi KS, Magyar DM, et al. Correlation of serum estradiol levels and ultrasound monitoring to assess follicular maturation. Fertil Steril. 1986; 46: 42–45.

    PubMed  CAS  Google Scholar 

  73. Marrs RP, Vargyas JM, March CM. Correlation of ultrasonic and endocrinologic measurements in human menopausal gonadotropin therapy. Am J Obstet Gynecol. 1983; 145: 417–21.

    PubMed  CAS  Google Scholar 

  74. Seibel MM, McArdle CR, Thompson IE, et al. The role of ultrasound in ovulation induction: a critical appraisal. Fertil Steril. 1981; 36: 573–77.

    PubMed  CAS  Google Scholar 

  75. Tulandi T, Hamilton EF, Arronet GH, et al. Ovulation induction by human menopausal gonadotropin with ultrasonic monitoring of the ovarian follicles. Int J Fertil. 1987; 32: 312–15.

    PubMed  CAS  Google Scholar 

  76. Hill LM, Coulam CB, Kislak SL, et al. Sonographic evaluation of the cervix during ovulation induction. Am J Obstet Gynecol. 1987; 157: 1170–74.

    PubMed  CAS  Google Scholar 

  77. Fleischer AC, Pittaway DE, Beard LA, et al. Sonographic depiction of endometrial changes occurring with ovulation induction. J Ultrasound Med. 1984; 3: 341–46.

    PubMed  CAS  Google Scholar 

  78. Insler V, Melmed H, Mashiach S, et al. A Functional classification of patients selected for gonadotropic therapy. Obstet Gynecol. 1968; 32: 620–26.

    PubMed  CAS  Google Scholar 

  79. Healy DL, Burger HG. Serum follicle-stimulating hormone, luteinizing hormone, and prolactin during the induction of ovulation with exogenous gonadotropin. J Clin Endocrinol Metab. 1983; 56: 474–78.

    PubMed  CAS  Google Scholar 

  80. Olson JL, Rebar RW, Schreiber JR, et al. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril. 1983; 39: 284–91.

    PubMed  CAS  Google Scholar 

  81. Collins RL, Williams RF, Hodgen GD. Endocrine consequences of prolonged ovarian hyperstimulation: Hyperprolactinemia, follicular atresia and premature luteinization. Fertil Steril. 1984; 42: 436–45.

    PubMed  CAS  Google Scholar 

  82. Hodgen GD. The dominant ovarian follicle. Fertil Steril. 1982; 38: 281–300.

    PubMed  CAS  Google Scholar 

  83. Stillman RJ, Williams RF, Lynch A, et al. Selective inhibition of follicle-stimulating hormone by porcine follicular fluid extracts in the monkey: effects on midcycle surges and pulsatile secretion. Fertil Steril. 1983; 40: 823–28.

    PubMed  CAS  Google Scholar 

  84. Schenken RS, Hodgen GD. Follicle-stimulating hormone induced ovarian hyperstimulation in monkeys: blockade of the luteinizing hormone surge. J Clin Endocrinol Metab. 1983; 57: 50–55.

    PubMed  CAS  Google Scholar 

  85. Laufer N, DeCherney AH, Tarlatzis BC, et al. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes. Fertil Steril. 1984; 42: 198–203.

    PubMed  CAS  Google Scholar 

  86. Tulandi T, Mclnnes RA, Arronet GH. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int J Fertil. 1984; 29: 113–17.

    PubMed  CAS  Google Scholar 

  87. Schenker JG, Weinstein D. Ovarian hyper-stimulation syndrome: a current survey. Fertil Steril. 1978; 30: 255–68.

    PubMed  CAS  Google Scholar 

  88. Navot D, Relou A, Birkenfeld A, et al. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988; 159: 210–15.

    PubMed  CAS  Google Scholar 

  89. Kirshon B, Doody MC, Cotton DB, et al. Management of ovarian hyperstimulation syndrome with chlorpheniramine maleate, mannitol, and invasive hemodynamic monitoring. Obstet Gynecol. 1988; 71: 485–87.

    PubMed  CAS  Google Scholar 

  90. Blankstein J, Shalev J, Saadon T, et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril. 1987; 47: 597–602.

    PubMed  CAS  Google Scholar 

  91. McArdle C, Seibel M, Hann LE, et al. The diagnosis of ovarian hyperstimulation (OHS): the impact of ultrasound. Fertil Steril. 1983; 39: 464–67.

    PubMed  CAS  Google Scholar 

  92. Narita O, Shimosuka Y, Suzuki M, et al. Induction of ovulation with human menopausal gonadotropin, with special reference to ovarian hyperstimulation syndrome and hormone excretion. Nagoya J Med Sci. 1980; 43: 7–13.

    PubMed  CAS  Google Scholar 

  93. Thaler I, Yoffe N, Kaftory JK, et al. Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach. Fertil Steril. 1981; 36: 110–13.

    PubMed  CAS  Google Scholar 

  94. Ben-Rafael Z, Dor J, Mashiach S, et al. Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/ human chorionic gonadotropin. Fertil Steril. 1983; 39: 157–61.

    PubMed  CAS  Google Scholar 

  95. Kemmann E, Bohrer M. Risk factors for spontaneous abortion in menotropintreated women. Fertil Steril. 1987; 48: 571–75.

    PubMed  Google Scholar 

  96. Gemzell C, Roos P. Pregnancies following treatment with human gonadotropins. Am J Obstet Gynecol. 1966; 94: 490–94.

    PubMed  CAS  Google Scholar 

  97. Bettendorf G, Braendle W, Sprotte C, et al. Overall results of gonadotropin therapy. In: Insler V, Bettendorf G, eds. Advances and diagnosis in treatment of infertility. New York: Elsevier North-Holland, 1981: 21–34.

    Google Scholar 

  98. Tricomi V, Ferrd M, Solish G. The ratio of male and female embryo as determined by the sex chromosome. Am J Obstet Gynecol. 1960; 75: 504–09.

    Google Scholar 

  99. Ben-Rafael Z, Matalon A, Blankstein J, et al. Male to female ratio after gonadotropin-induced ovulation. Fertil Steril. 1986; 45: 36–40.

    PubMed  CAS  Google Scholar 

  100. Spadoni LR, Cox DW, Smith DC. Use of human menopausal gonadotropin for the induction of ovulation. Am J Obstet Gynecol. 1974; 120: 988–93.

    PubMed  CAS  Google Scholar 

  101. Ben-Rafael Z, Mashiach S, Oelsner G, et al. Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy. Fertil Steril. 1981; 36: 560–64.

    PubMed  CAS  Google Scholar 

  102. Lam SY, Baker G, Pepperell R, et al. Treatment-independent pregnancies after cessation of gonadotropin ovulation induction in women with oligomenorrhea and anovulatory menses. Fertil Steril. 1988; 50: 26–30.

    PubMed  CAS  Google Scholar 

  103. March CM. The use of Pergonal for the induction of ovulation. Clin Obstet Gynecol. 1984; 27: 966–74.

    PubMed  CAS  Google Scholar 

  104. Wang CF, Gemzell C. The use of human gonadotropins for induction of ovulation in women with polycystic ovary disease. Fertil Steril. 1980; 33: 479–86.

    PubMed  CAS  Google Scholar 

  105. Gemzell C. Induction of ovulation with human gonadotropins. Recent Prog Horm Res. 1965; 21: 179–97.

    PubMed  CAS  Google Scholar 

  106. Schoemaker J, Wentz AC, Jones GS, et al. Stimulation of follicular growth with “pure” FSH in patients with anovulation and elevated LH levels. Obstet Gynecol. 1978; 51: 270–77.

    PubMed  CAS  Google Scholar 

  107. Collins RL, Gidwani GP, Seiler JC. Improved ovulation in women with PCO receiving exogenous gonadotropins and a GnRH agonist concurrently. 70th Meeting of the Endocrine Society. New Orleans, LA, 1988; 840.

    Google Scholar 

  108. Lewinthal D, Taylor PJ, Pattison HA, et al. Induction of ovulation with leuprolide acetate and human menopausal gonadotropin. Fertil Steril. 1988; 49: 585–88.

    PubMed  CAS  Google Scholar 

  109. Dodson WC, Hughes CL, Whitesides DB, et al. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab. 1987; 65: 95–100.

    PubMed  CAS  Google Scholar 

  110. Charbonnel B, Krempf M, Blanchard P, et al. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins. Fertil Steril. 1987; 47: 920–24.

    PubMed  CAS  Google Scholar 

  111. Lanzone A, Fulghesu AM, Spina MA, et al. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly follicle-stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1987; 65: 1253–58.

    PubMed  CAS  Google Scholar 

  112. March CM, Tredway DR, Michelle DR Jr. Affect of clomiphene citrate upon amount and duration of human menopausal gonadotropin therapy. Am J Obstet Gynecol. 1976; 125: 699–704.

    PubMed  CAS  Google Scholar 

  113. Jarrell J, McInnes R, Cooke R, et al. Observations on the combination of clomiphene citrate-human menopausal gonadotropinhuman chorionic gonadotropin in the management of anovulation. Fertil Steril. 1981; 35: 634–37.

    PubMed  CAS  Google Scholar 

  114. Evron S, Navot D, Laufer N, et al. Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease. Fertil Steril. 1983; 40: 183–86.

    PubMed  CAS  Google Scholar 

  115. Diamant YZ, Friedler S. Ovulation induction with pulsatile human menopausal gonadotropins (HMG) administration. Eur J Obstet Gynecol Reprod Biol. 1987; 25: 303–13.

    PubMed  Google Scholar 

  116. Friedler S, Diamant YZ. Ovulation induction with pulsatile human menopausal gonadotropin (HMG) administration. Eur J Obstet Gynecol Reprod Biol. 1987; 25: 303–13.

    PubMed  CAS  Google Scholar 

  117. Yuen BH, Pride SM, Sime MO. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy. Am J Obstet Gynecol. 1984; 148: 508–12.

    Google Scholar 

  118. Kemmann E, Brandeis VT, Shelden RM, et al. The initial experience with the use of a portable infusion pump in the delivery of human menopausal gonadotropins. Fertil Steril. 1983; 40: 448–53.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Robert L. Collins
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Reproductive Endocrinology and Infertility/A81, Department of Gynecology, The Cleveland Clinic Foundation, 44195-5037, Cleveland, Ohio, USA

    Robert L. Collins M.D. (Director of Education) (Director of Education)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Collins, R.L. (1991). Recent Progress in Gonadotropin Therapy. In: Collins, R.L. (eds) Ovulation Induction. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3026-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3026-7_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7766-8

  • Online ISBN: 978-1-4612-3026-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation